A Study of Inlexisertib (DCC-3116) in Combination With Anticancer Therapies in Participants With Advanced Malignancies
Deciphera Pharmaceuticals, LLC
Deciphera Pharmaceuticals, LLC
National Institutes of Health Clinical Center (CC)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Travera Inc
The Netherlands Cancer Institute
Ascentage Pharma Group Inc.
Bayer
Asan Medical Center
Asan Medical Center
Asan Medical Center
Asan Medical Center
Zai Lab (Hong Kong), Ltd.
GlaxoSmithKline
Cogent Biosciences, Inc.
Hebei Medical University
Novartis
AstraZeneca
University of California, San Diego
Centre Oscar Lambret
Centre Oscar Lambret
Dana-Farber Cancer Institute
National Institutes of Health Clinical Center (CC)
University of Kentucky
Kumquat Biosciences Inc.
CStone Pharmaceuticals
Deciphera Pharmaceuticals, LLC
Deciphera Pharmaceuticals, LLC
Kura Oncology, Inc.
Cogent Biosciences, Inc.
Ningbo Newbay Technology Development Co., Ltd
University of Nebraska
Novartis
National Health Research Institutes, Taiwan
Taiho Pharmaceutical Co., Ltd.
M.D. Anderson Cancer Center
Centre Leon Berard
Stanford University
Deciphera Pharmaceuticals, LLC
Universität Duisburg-Essen
iOMEDICO AG
Memorial Sloan Kettering Cancer Center
IDRx Inc. - A GSK Company
Sarcoma Alliance for Research through Collaboration
Novartis
Novelty Nobility, Inc.
Gazi University
Maria Sklodowska-Curie National Research Institute of Oncology
University of Miami
Institut Bergonié